Sera Prognostics (NasdaqGM:SERA) Q1 2026 Earnings call May 06, 2026 05:00 PM ET Speaker3Ladies and gentlemen, welcome to Sera Prognostics 1st quarter 2026 financial results conference call. At this time, all lines are in listen-only mode. Following the presentation, we will conduct a question and answer session. If at any time during this call you require immediate assistance, please press star zero for the operator. Please be advised that this call is being recorded today, Wednesday, May 6, 2026. I will no ...

If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh. To ensure this doesn't happen in the future, please enable Javascript and cookies in your browser. ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number: 001-40606 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2026 OR SERA PROGNOSTICS, INC. (Exact Name of Registrant as Specified in its Charter) | Delaware | 26-1911522 | | --- | --- | | (State or other jur ...

SERA PROGNOSTICS REPORTS FIRST QUARTER 2026 FINANCIAL RESULTS Salt Lake City – May 6, 2026 – Sera Prognostics Inc., The Pregnancy Company® (Nasdaq: SERA), focused on improving maternal and neonatal health by providing innovative pregnancy biomarker information to doctors and patients, today announced financial results for the first quarter ended March 31, 2026. Key First Quarter and Recent Highlights: • Published Landmark PRIME Randomized Trial: Study in 5,018 women showing the PreTRM® test reduced early pr ...